Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Integrated Biopharma Inc (INB) since 2012 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Integrated Biopharma Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1016504.
Total stock buying since 2012: $0.
Total stock sales since 2012: $22,500.
Total stock option exercises since 2012: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2012 | 0 | $0 | 250,000 | $22,500 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2012-06 | 0 | $0 | 250,000 | $22,500 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-06-27 | Kay E Gerald (CEO AND PRESIDENT) | Sale | 250,000 | .09 | 22,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of INB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Integrated Biopharma Inc (symbol INB, CIK number 1016504) see the Securities and Exchange Commission (SEC) website.